欧洲药物组合物专利判例

Takeda Pharmaceutical Co. Ltd. v. Actavis Group PTC EHF: In this case, Takeda Pharmaceutical filed a patent infringement suit against Actavis Group for their generic version of Takeda's combination drug, which contained the active ingredients alogliptin and metformin. The court found that Actavis's product infringed on Takeda's patent and ordered them to stop selling the product.

Novartis AG v. Teva Pharmaceuticals USA, Inc.: Novartis filed a patent infringement suit against Teva Pharmaceuticals for their generic version of Novartis's combination drug, which contained the active ingredients valsartan and hydrochlorothiazide. The court found that Teva's product infringed on Novartis's patent and ordered them to stop selling the product.

AstraZeneca AB v. Mylan Pharmaceuticals Inc.: AstraZeneca filed a patent infringement suit against Mylan Pharmaceuticals for their generic version of AstraZeneca's combination drug, which contained the active ingredients budesonide and formoterol. The court found that Mylan's product infringed on AstraZeneca's patent and ordered them to stop selling the product.

Sanofi-Aventis Deutschland GmbH v. Glenmark Pharmaceuticals Ltd.: Sanofi-Aventis filed a patent infringement suit against Glenmark Pharmaceuticals for their generic version of Sanofi-Aventis's combination drug, which contained the active ingredients irbesartan and hydrochlorothiazide. The court found that Glenmark's product infringed on Sanofi-Aventis's patent and ordered them to stop selling the product.

Pfizer Inc. v. Sandoz Inc.: Pfizer filed a patent infringement suit against Sandoz for their generic version of Pfizer's combination drug, which contained the active ingredients amlodipine and atorvastatin. The court found that Sandoz's product infringed on Pfizer's patent and ordered them to stop selling the product